Tag | Content |
---|
EnhancerAtlas ID | HS109-12853 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr2:136983480-136984330 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
SPIC | MA0687.1 | chr2:136983855-136983869 | TCCTTCCCCTTTTT | - | 6 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_10274 | chr2:136983021-136984628 | CD19_Primary | SE_11065 | chr2:136982360-136986775 | CD20 | SE_39801 | chr2:136983435-136984140 | Jurkat | SE_61425 | chr2:136945577-137039880 | Toledo | SE_62403 | chr2:136962507-137014815 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I136225 | chr2 | 136982960 | 136984370 |
|
Enhancer Sequence | TTGAAGTCTT GACTTCCTCA GCTGTAGTTT AAAGAAAGTT CTTTCCCTTC CAGACTAGCT 60 GTAGGGGAGC ACAGCTTTTG CATAGAATTC AAGGTGGGGG CTTCAGAGAG ATGGCAAGGG 120 AGGGCAGCTC TGTGCCCCCT CAGCACTCCC TGGCAGGAGG CCTGTGATGT GACATCCCAG 180 GGACCCTGGG TGTGCGTTTG TTTGGTCTTG GTTTCTAGGC TTCAGTGAGG GTTATTATCT 240 TATTGTTTCC TGTTCCCTTG GCCTCACGTC AATTCTGTCT GATGCCTACA CCTTCGAGGT 300 CTCTGTTTTG ACACGCGGTT TGTGGCTGGG AACCCCACAG TGTCCCGAAA ACATTTGCTT 360 GACCTGTTGG GGACATCCTT CCCCTTTTTA GTGAAACAAT GCCTTCCAGA GCACAAGGGC 420 TTGAGGGCTT TGGACCTTTC CAGCAGTGTC AAATTTAGAT TCCAAATGTC AATCTTGCCG 480 TGGCTTCATC CTTGACTTCT CTTTCTTGAG AATCTATGCT CTTTGGCTAA CAGCTAAGGG 540 CCAGTTAGCT GCCTGCTTTC ACAGTTGTTG TCTGTGGAAA TTTGATATCA GCTGTGAAGT 600 GTGTGCCTGG TAATGAACAC AGTACAGCTC TGCAAGCACT GTAGCTCATG GTGAAGTACT 660 GCAGGCAGAT TGGACAGGGA TTCAGGAGAA TCCTGAATTT AACTTGGAGA GGGGTCTGTT 720 TAGGATGTTA ATCTGCATTT CCTGTCCTGG AAGACAAAGC ACAGAAGGTT TGGAATATAG 780 CCTGTGTTTG GCTTTGAATG CCAAACAGGT GCTGACACTG AGCCTTTTCC ACAGCTGCCC 840 TGGGATGACA 850
|